This is a clinical trial which aims at using gene corrected grafts to treat chronic wounds of three patients with recessive dystrophic epidermolysis bullosa. As the grafts are gene corrected in all layers they have the potential to permanently heal the areas they are grafted on to.
It ran from 12:00 PM, 3 December 2019 to 12:00 PM, 10 December 2019
Registered Charity in England and Wales (1158672)
Cure EB has given us hope for the future that there could possibly be a cure for this terrible condition. We can only imagine how happy we could be as parents if our one and only dream came true and Poppy could live with a life without pain.
Epidermolysis Bullosa is currently an incurable condition with no effective treatment. It often leads to chronic wounds that take time to heal, or do not heal at all, sometimes for years. Management of these wounds includes applying dressings and ointments in an effort to promote closure and avoid infection. These wounds are very painful, like severe burns and they lead to contracting scars and an increased risk of skin cancer in the severest forms. Internal skin is also affected.
Our mission is to find effective treatments for and eventually to cure EB (epidermolysis bullosa) This is a genetic skin condition that leads to blistering and skin loss at the slightest friction.It is "Hard to say. Hell to live with" and children and adults with the condition live in constant pain from the burn like wounds formed. The charity funds medical research focussing on gene modifying and gene corrective strategies aimed at translation into effective treatments and eventually a cure.
Please upgrade your browser to continue.